Candesartan Cilexetil/Hydrochlorothiazide Treatment in High-Risk Patients with Type 2 Diabetes Mellitus and Microalbuminuria: The CHILI T2D Study

Author： Ketelhut Reinhard  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.30, Iss.5, 2010-05, pp. : 301-311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antihypertensive Treatment in Elderly Patients Aged 75 Years or Over: A 24-Week Study of the Tolerability of Candesartan Cilexetil in Relation to Hydrochlorothiazide

By Neldam S.  

Drugs & Aging, Vol. 18, Iss. 3, 2001-03 ,pp. : 225-232

Adis International

Access to resources Recommend Favorite

Angiotensin-converting Enzyme Gene Polymorphism as a Potent Risk Factor for Developing Microalbuminuria in Japanese Patients with Type 2 Diabetes Mellitus: a 9-Year Follow-up Study

By Okuno S   Utsugi T   Ohno T   Ohyama Y   Uchiyama T     Kurabayashi M  

The Journal of International Medical Research, Vol. 31, Iss. 4, 2003-07 ,pp. : 290-298

Field House Publishing

Access to resources Recommend Favorite

Metformin may reduce the risk of cancer in patients with type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Postmarketing Surveillance of Acarbose Treatment in Taiwanese Patients with Type 2 Diabetes Mellitus

By Hung Yi-Jen  

Clinical Drug Investigation, Vol. 26, Iss. 10, 2006-01 ,pp. : 559-565

Adis International

Access to resources Recommend Favorite

A fixed combination of rosiglitazone plus metformin improves glycaemic control and cardiovascular risk factors in patients with type 2 diabetes mellitus (T2DM)

By  

Inpharma, Vol. 1, Iss. 1546, 2006-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite